Noninvasix

About:

Noninvasix is developing the first non-invasive technology for monitoring the oxygenation of veins.

Website: http://www.noninvasix.com/

Twitter/X: noninvasix

Top Investors: Health Wildcatters, TMC Venture Fund, AngelMD, Green Park & Golf Ventures, Philips Healthcare

Description:

Noninvasix, Inc. (the “Company” or “Noninvasix”) is a medical technology company that has developed a novel solution to non-invasively monitor for the first time, oxygen sufficiency in organs and veins. The Company was founded in 2007 by Dr. Donald Prough and Dr. Rinat Esenaliev at the University of Texas Medical Branch (UTMB) and is based out of Houston, Texas. The Company has raised over $6.8 million to date including a seed round in Q4 2021. The platform technology of the Company has been developed with $6 million in grants from the NIH and DOD. The Company has also been a part of prestigious accelerator programs such as Philips Healthworks, TMCx, JLabs, Health Wildcatters and has won multiple awards for their innovation. The non-invasive technology has been clinically validated in multiple peer-reviewed journals. The IP portfolio of the Company includes 9 U.S. and 8 global patents.